NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
National Guideline Centre (UK). Venous thromboembolism in over 16s: Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. London: National Institute for Health and Care Excellence (NICE); 2018 Mar. (NICE Guideline, No. 89.)
December 2019: In recommendation 1.3.5 the British Standards for anti-embolism hosiery were updated because BS 6612 and BS 7672 have been withdrawn. August 2019: Recommendation 1.12.11 (1.5.30 in this document) was amended to clarify when anti-embolism stockings can be used for VTE prophylaxis for people with spinal injury.
Venous thromboembolism in over 16s: Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism.
Show detailsThe September 2014 version of the NICE code of practice for declaring and dealing with conflicts of interest policy was applied to this guideline.
Peter Barry (Chair from April 2017)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (02.03.2016) | Not yet recruited | N/A | N/A |
|
Second meeting (22.04.2016) | Not yet recruited | N/A | N/A |
|
Third meeting (01.06.2016) | Not yet recruited | N/A | N/A |
|
Fourth meeting (20.07.2016) | Not yet recruited | N/A | N/A |
|
Fifth meeting (16.09.2016) | Not yet recruited | N/A | N/A |
|
Sixth meeting (19.10.2016) | Not yet recruited | N/A | N/A |
|
Seventh meeting (01.12.2016) | Not yet recruited | N/A | N/A |
|
Eight meeting (05.01.2017) | Not yet recruited | N/A | N/A |
|
Ninth meeting (08.02.2017) | Not yet recruited | N/A | N/A |
|
Tenth meeting (09.02.2017) | Not yet recruited | N/A | N/A |
|
Eleventh meeting (15.03.2017) | Not yet recruited | N/A | N/A |
|
Twelfth meeting (19.04.2017) | None | N/A | N/A |
|
Thirteenth meeting (25.05.2017) | None | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | None | N/A | N/A |
|
Fifteenth meeting (22.06.2017) |
Attended an educational meeting on the subject of paediatric critical care transport, where the company CareFusion sponsored room hire, lunch and mid - afternoon refreshments. The meeting was not about Venous ThromboEmbolism, and as far as I am aware, CareFusion do not market any of the interventions under consideration by the committee. I was not paid to attend the meeting. | Personal non-financial non-specific | Declare and participate |
|
Sixteenth meeting (28.07.2017) | No change to existing declarations | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | No change to existing declarations | N/A | N/A |
Jagjot Chahal
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (02.03.2016) | Not yet recruited | N/A | N/A |
|
Second meeting (22.04.2016) | Not yet recruited | N/A | N/A |
|
Third meeting (01.06.2016) | None | N/A | N/A |
|
Fourth meeting (20.07.2016) | None | N/A | N/A |
|
Fifth meeting (16.09.2016) | None | N/A | N/A |
|
Sixth meeting (19.10.2016) | None | N/A | N/A |
|
Seventh meeting (01.12.2016) | None | N/A | N/A |
|
Eight meeting (05.01.2017) | None | N/A | N/A |
|
Ninth meeting (08.02.2017) | None | N/A | N/A |
|
Tenth meeting (09.02.2017) | None | N/A | N/A |
|
Eleventh meeting (15.03.2017) | None | N/A | N/A |
|
Twelfth meeting (19.04.2017) | Abstract accepted for the ISTH 2017 conference on the safety and cost-effectiveness of LMWH in comparison to NOACs for treatment indications. | Personal non-financial specific | Declare and participate |
|
Thirteenth meeting (25.05.2017) | No change to existing declarations. | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | No change to existing declarations | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | No change to existing declarations | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | Publication of a CPD learning article in the Pharmaceutical Journal: Heparin-induced thrombocytopenia. | Personal non-financial specific | Declare and participate |
|
Seventeenth meeting (07.12.2017) | No change to existing declarations | N/A | N/A |
Deepak Chandra
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
| On application | None | N/A | N/A |
|
First meeting (02.03.2016) | No change to existing declarations | N/A | N/A |
|
Second meeting (22.04.2016) | No change to existing declarations | N/A | N/A |
|
Third meeting (01.06.2016) | Pharmaceutical company support for venue hire, catering cost and keynote speaker for launch of thrombosis and anticoagulation services. | Non-personal financial specific | Declare and participate |
|
Fourth meeting (20.07.2016) | No change to existing declarations | N/A | N/A |
|
Fifth meeting (16.09.2016) | No change to existing declarations | N/A | N/A |
|
Sixth meeting (19.10.2016) | No change to existing declarations | N/A | N/A |
|
Seventh meeting (01.12.2016) | No change to existing declarations | N/A | N/A |
|
Eight meeting (05.01.2017) | No change to existing declarations | N/A | N/A |
|
Ninth meeting (08.02.2017) | No change to existing declarations | N/A | N/A |
|
Tenth meeting (09.02.2017) | No change to existing declarations | N/A | N/A |
|
Eleventh meeting (15.03.2017) | No change to existing declarations | N/A | N/A |
|
Twelfth meeting (19.04.2017) | No change to existing declarations | N/A | N/A |
|
Thirteenth meeting (25.05.2017) | Apologies received | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | No change to existing declarations | N/A | N/A |
|
Fifteenth meeting (22.06.2017) |
Participation in APEX study as a site investigator. Did not have any role in design of study or data review and final publication Betrixaban was not included in any review protocol for this guideline. | Personal non-financial non-specific | Declare and participate |
|
Sixteenth meeting (28.07.2017) | Apologies received | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | No change to existing declarations | N/A | N/A |
Sarah Chissell (obstetric subgroup member)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (14.03.2017) | None | N/A | N/A |
|
Second meeting (24.05.2017) | None | N/A | N/A |
Ian Donald
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
| On application |
Took part in a medical advisory panel for Vifor Pharmaceuticals in 2015. Secondary Care Member of the Board for Bristol Clinical Commissioning Group. | Personal financial non-specific | Declare and participate |
|
First meeting (02.03.2016) | No change to existing declarations | N/A | N/A |
|
Second meeting (22.04.2016) | No change to existing declarations | N/A | N/A |
|
Third meeting (01.06.2016) | No change to existing declarations | N/A | N/A |
|
Fourth meeting (20.07.2016) | No change to existing declarations | N/A | N/A |
|
Fifth meeting (16.09.2016) | No change to existing declarations | N/A | N/A |
|
Sixth meeting (19.10.2016) | No change to existing declarations | N/A | N/A |
|
Seventh meeting (01.12.2016) | No change to existing declarations | N/A | N/A |
|
Eight meeting (05.01.2017) | No change to existing declarations | N/A | N/A |
|
Ninth meeting (08.02.2017) | No change to existing declarations | N/A | N/A |
|
Tenth meeting (09.02.2017) | No change to existing declarations | N/A | N/A |
|
Eleventh meeting (15.03.2017) | No change to existing declarations | N/A | N/A |
|
Twelfth meeting (19.04.2017) | No change to existing declarations | N/A | N/A |
|
Thirteenth meeting (25.05.2017) | Apologies received. | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | No change to existing declarations | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | No change to existing declarations | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | No change to existing declarations | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | Apologies received | N/A | N/A |
Xavier Griffin
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
| On application | Co-editor Bone Joint and Musculoskeletal Trauma Cochrane Group with multiple systematic reviews in trauma surgery. | Personal non-financial specific | Declare and participate |
| Grants (paid to University) from X-Bolt Orthopaedics for two investigator-initiated, industry funded randomised trials testing a novel implant for hip fracture fixation. | Non-personal financial non-specific | Declare and participate | |
| Grant from Orthodynamics (paid to University) for investigator-initiated, industry-funded randomised trials testing a novel implant for total hip arthroplasty for fracture. | Non-personal financial non-specific | Declare and participate | |
| NIHR RfPB grant (paid to NHS Trust) for a randomised trial testing alternative arthroplasties for hip fracture. | Non-personal financial non-specific | Declare and participate | |
|
First meeting (02.03.2016) | No change to existing declarations | N/A | N/A |
|
Second meeting (22.04.2016) | No change to existing declarations | N/A | N/A |
|
Third meeting (01.06.2016) | No change to existing declarations | N/A | N/A |
|
Fourth meeting (20.07.2016) | No change to existing declarations | N/A | N/A |
|
Fifth meeting (16.09.2016) | No change to existing declarations | N/A | N/A |
|
Sixth meeting (19.10.2016) | No change to existing declarations | N/A | N/A |
|
Seventh meeting (01.12.2016) | No change to existing declarations | N/A | N/A |
|
Eight meeting (05.01.2017) | No change to existing declarations | N/A | N/A |
|
Ninth meeting (08.02.2017) | No change to existing declarations | N/A | N/A |
|
Tenth meeting (09.02.2017) | No change to existing declarations | N/A | N/A |
|
Eleventh meeting (15.03.2017) |
Joining lower limb immobilisation modelling study for HTA as a stakeholder member. Study not yet started.
https://www | Non-personal financial specific | Declare and participate |
|
Twelfth meeting (19.04.2017) | No change to existing declarations | N/A | N/A |
|
Thirteenth meeting (25.05.2017) | No change to existing declarations | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | No change to existing declarations | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | No change to existing declarations | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | No change to existing declarations | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | No change to existing declarations | N/A | N/A |
Nihal Gurusinghe (co-opted member)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
Eight meeting (05.01.2017) | None | N/A | N/A |
|
Twelfth meeting (19.04.2017) | None | N/A | N/A |
Elizabeth Houghton
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (02.03.2016) | None | N/A | N/A |
|
Second meeting (22.04.2016) | None | N/A | N/A |
|
Third meeting (01.06.2016) | None | N/A | N/A |
|
Fourth meeting (20.07.2016) | None | N/A | N/A |
|
Fifth meeting (16.09.2016) | None | N/A | N/A |
|
Sixth meeting (19.10.2016) | None | N/A | N/A |
|
Seventh meeting (01.12.2016) | None | N/A | N/A |
|
Eight meeting (05.01.2017) | None | N/A | N/A |
|
Ninth meeting (08.02.2017) | None | N/A | N/A |
|
Tenth meeting (09.02.2017) | None | N/A | N/A |
|
Eleventh meeting (15.03.2017) | None | N/A | N/A |
|
Twelfth meeting (19.04.2017) | None | N/A | N/A |
|
Thirteenth meeting (25.05.2017) | None | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | None | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | Apologies received. | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | None | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | None | N/A | N/A |
Beverley Hunt
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
| On application | Medical director and trustee of Thrombosis UK. | Personal non-financial specific | Declare and participate |
|
First meeting (02.03.2016) | Thrombosis UK now accepts payment from pharmaceutical companies. BH has previously declared her involvement with Thrombosis UK. | Non-personal financial specific | Declare and participate |
|
Second meeting (22.04.2016) | No change to existing declarations | N/A | N/A |
|
Third meeting (01.06.2016) | Apologies received | N/A | N/A |
|
Fourth meeting (20.07.2016) | Apologies received | N/A | N/A |
|
Fifth meeting (16.09.2016) | No change to existing declarations | N/A | N/A |
|
Sixth meeting (19.10.2016) | No change to existing declarations | N/A | N/A |
|
Seventh meeting (01.12.2016) | Attended the All-party parliamentary thrombosis group (APPTG) round table. | Personal non-financial specific | Declare and participate |
|
Eight meeting (05.01.2017) | No change to existing declarations | N/A | N/A |
|
Ninth meeting (08.02.2017) | Principal Investigator for NIHR funded trial of stockings for VTE prophylaxis in surgical patients | Non-personal financial specific | Declare and participate |
|
Tenth meeting (09.02.2017) | No change to existing declarations | N/A | N/A |
|
Eleventh meeting (15.03.2017) | Declared 20 recent articles 4 related to VTE prophylaxis. None applicable to topic under discussion:
| Personal non-financial non-specific | Declare and participate |
|
Twelfth meeting (19.04.2017) | Apologies received | N/A | N/A |
|
Thirteenth meeting (25.05.2017) | No change to existing declarations | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | No change to existing declarations | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | No change to existing declarations | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | Chaired meeting Thrombosis TB. | Personal non-financial non-specific interest | Declare and participate |
|
Seventeenth meeting (07.12.2017) | No change to existing declarations | N/A | N/A |
Josie Jenkinson (co-opted member)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
Ninth meeting (08.02.2017) | None | N/A | N/A |
Nicholas Levy (co-opted member)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
| On application | None | N/A | N/A |
Donald McBride (orthopaedic subgroup member)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (24.06.2016) | None | N/A | N/A |
|
Second meeting (20.10.2016) | None | N/A | N/A |
|
Third meeting (27.01.2017) | None | N/A | N/A |
|
Fourth meeting (31.03.2017) | None | N/A | N/A |
|
Fifth meeting (26.05.2017) | None | N/A | N/A |
|
Sixth meeting (22.06.2017) | None | N/A | N/A |
Colin Nnadi (orthopaedic subgroup member)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (24.06.2016) | None | N/A | N/A |
|
Second meeting (20.10.2016) | None | N/A | N/A |
|
Third meeting (27.01.2017) | None | N/A | N/A |
|
Fourth meeting (31.03.2017) | None | N/A | N/A |
|
Fifth meeting (26.05.2017) | None | N/A | N/A |
|
Sixth meeting (22.06.2017) | None | N/A | N/A |
Simon Noble
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
| On application | Has given lectures for Leo Pharma and Pfizer in the past 12 months; no fee taken. | Non-personal non-financial specific | Declare and participate |
| Medical Director (Wales) for Thrombosis UK (formerly Lifeblood). | Personal non-financial specific | Declare and participate | |
|
First meeting (02.03.2016) | Thrombosis UK now accepts payment from pharmaceutical companies. SN has previously declared his involvement with Thrombosis UK. | Non-personal financial specific | Declare and participate |
|
Second meeting (22.04.2016) | No change to existing declarations | N/A | N/A |
|
Third meeting (01.06.2016) | Apologies received | N/A | N/A |
|
Fourth meeting (20.07.2016) | Apologies received | N/A | N/A |
|
Fifth meeting (16.09.2016) | No change to existing declarations | N/A | N/A |
|
Sixth meeting (19.10.2016) | No change to existing declarations | N/A | N/A |
|
Seventh meeting (01.12.2016) | No change to existing declarations | N/A | N/A |
|
Eight meeting (05.01.2017) | No change to existing declarations | N/A | N/A |
|
Ninth meeting (08.02.2017) | No change to existing declarations | N/A | N/A |
|
Tenth meeting (09.02.2017) | No change to existing declarations | N/A | N/A |
|
Eleventh meeting (15.03.2017) | Apologies received | N/A | N/A |
|
Twelfth meeting (19.04.2017) | Apologies received | N/A | N/A |
|
Thirteenth meeting (25.05.2017) | No change to existing declarations | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | Apologies received | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | Apologies received | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | Apologies received | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | No change to existing declarations | N/A | N/A |
Rachel Rayment (obstetric subgroup member)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
| On application | Attendance at Bayer annual expert clotters meeting 2016 (travel, accommodation and food). | Personal financial specific |
Declare and participate (relates to accepted expenses under DOI policy) |
|
First meeting (14.03.2017) |
Bayer annual expert clotters meeting 2017. CSL expenses for EAHAD 2017 | Personal, financial, specific |
Declare and participate (relates to accepted expenses under DOI policy) |
|
Second meeting (24.05.2017) | No change to existing declarations. | N/A | N/A |
Mike Reed (orthopaedic subgroup member)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
| On application | No links to manufacturers or bodies involved in VTE. | ||
| Grants: | |||
| Academic Health Science Network - NENC and Heraeus Medical - Spreading the use of high dose antibiotic cement to prevent infection following surgery for hip fracture (lead applicant) −£84,452 | Non-personal, financial, non-specific | Declare and participate | |
| Stryker - A randomised multicentre trial of 964 patients comparing the Thompsons stem with the Exeter/unitrax for hemiarthroplasty (chief investigator) £313,003 with treatment costs | Non-personal, financial, non-specific | Declare and participate | |
| Heraeus Medical GMBH - Investigation of NucB anti-biofilm role in joints (co-applicant) £84,000 | Non-personal, financial, non-specific | Declare and participate | |
| Zimmer Educational fellowship grant £45,923 | Non-personal, financial, non-specific | Declare and participate | |
| Convatec Clinical audit: £30,000 | Non-personal, financial, non-specific | Declare and participate | |
| Speaker fees: | |||
|
Zimmer Biomet Heraeus | Personal, financial, non-specific | Declare and participate | |
| Personal, financial, non-specific | Declare and participate | ||
|
First meeting (24.06.2016) | No change to existing declarations. | N/A | N/A |
|
Second meeting (20.10.2016) | No change to existing declarations | N/A | N/A |
|
Third meeting (27.01.2017) | No change to existing declarations | N/A | N/A |
|
Fourth meeting (31.03.2017) | No changes to existing declarations | N/A | N/A |
|
Fifth meeting (26.05.2017) | None | N/A | N/A |
|
Sixth meeting (22.06.2017) | None | N/A | N/A |
Alexandra Rees
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (02.03.2016) | None | N/A | N/A |
|
Second meeting (22.04.2016) | None | N/A | N/A |
|
Third meeting (01.06.2016) | Apologies received | N/A | N/A |
|
Fourth meeting (20.07.2016) | None | N/A | N/A |
|
Fifth meeting (16.09.2016) | None | N/A | N/A |
|
Sixth meeting (19.10.2016) | None | N/A | N/A |
|
Seventh meeting (01.12.2016) | None | N/A | N/A |
|
Eight meeting (05.01.2017) | None | N/A | N/A |
|
Ninth meeting (08.02.2017) | None | N/A | N/A |
|
Tenth meeting (09.02.2017) | None | N/A | N/A |
|
Eleventh meeting (15.03.2017) | None | N/A | N/A |
|
Twelfth meeting (19.04.2017) | None | N/A | N/A |
|
Thirteenth meeting (25.05.2017) | None | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | Apologies received | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | None | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | None | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | Apologies received | N/A | N/A |
Nigel Rossiter (orthopaedic subgroup member)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (24.06.2016) | Director OrthoISIS Medical Indemnity Insurance Scheme (remunerated) | Personal financial non-specific | Declare and participate |
| Trustee Primary Trauma Care Foundation charity (not remunerated) | Personal non-financial non-specific | Declare and participate | |
|
Second meeting (20.10.2016) | No change to existing declarations | N/A | N/A |
|
Third meeting (27.01.2017) | No change to existing declarations | N/A | N/A |
|
Fourth meeting (31.03.2017) | No change to existing declarations | N/A | N/A |
|
Fifth meeting (26.05.2017) | None | N/A | N/A |
|
Sixth meeting (22.06.2017) | None | N/A | N/A |
Karen Sheares
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
| On application | Received educational support (travel, accommodation and registration) from GSK to attend the European Respiratory Society Annual Congress in September 2015. | Personal financial non-specific |
Declare and participate (relates to accepted expenses under DOI policy) |
|
First meeting (02.03.2016) | No change to existing declarations | N/A | N/A |
|
Second meeting (22.04.2016) | No change to existing declarations | N/A | N/A |
|
Third meeting (01.06.2016) | Giving a VTE update lecture for the Royal College of Physicians in June 2016. | Personal non-financial specific | Declare and participate |
|
Fourth meeting (20.07.2016) | No change to existing declarations | N/A | N/A |
|
Fifth meeting (16.09.2016) | No change to existing declarations | N/A | N/A |
|
Sixth meeting (19.10.2016) | Educational support to attend the Annual European respiratory Society International Conference from Actelion (paid for registration). | Personal financial non-specific |
Declare and participate (relates to accepted expenses under DOI policy) |
|
Seventh meeting (01.12.2016) | No change to existing declarations | N/A | N/A |
|
Eight meeting (05.01.2017) | No change to existing declarations | N/A | N/A |
|
Ninth meeting (08.02.2017) | No change to existing declarations | N/A | N/A |
|
Tenth meeting (09.02.2017) | No change to existing declarations | N/A | N/A |
|
Eleventh meeting (15.03.2017) | No change to existing declarations | N/A | N/A |
|
Twelfth meeting (19.04.2017) |
Apologies received. Receiving educational support (registration, accommodation and travel) from Actelion to attend the American Thoracic Society Annual Congress in May 2017. | Personal financial non-specifc |
Declare and participate (relates to accepted expenses under DOI policy) |
|
Thirteenth meeting (25.05.2017) | No new DOIs | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | No new DOIs | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | Apologies received | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | Apologies received | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | Educational support from Actelion for: | ||
| American Thoracic Society Annual Meeting in Washington May 2017-registration fee, travel and accommodation | Personal financial non-specific |
Declare and participate (relates to accepted expenses under the DoI policy) | |
| Registration fee to attend the International Chronic Thromboembolic Pulmonary Hypertension Conference June 2017 in Leuven, Belgium | Personal financial specific |
Declare and participate (relates to accepted expenses under the DoI policy) | |
| Skills, Excellence and Leadership in Pulmonary Hypertension Clinical Leadership Training Programme with the University of Cambridge Judge Business School from Nov 2017 | Personal financial non-specific |
Declare and participate (relates to accepted expenses under the DoI policy) |
Kimberley Skinner (obstetric subgroup member)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (14.03.2017) | None | N/A | N/A |
|
Second meeting (24.05.2017) | None | N/A | N/A |
Gerard Stansby (Chair from September 2015–March 2017; Clinical Lead from April 2017)
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (02.03.2016) | None | N/A | N/A |
|
Second meeting (22.04.2016) | None | N/A | N/A |
|
Third meeting (01.06.2016) | None | N/A | N/A |
|
Fourth meeting (20.07.2016) | None | N/A | N/A |
|
Fifth meeting (16.09.2016) | None | N/A | N/A |
|
Sixth meeting (19.10.2016) | None | N/A | N/A |
|
Seventh meeting (01.12.2016) | None | N/A | N/A |
|
Eight meeting (05.01.2017) | None | N/A | N/A |
|
Ninth meeting (08.02.2017) | Author on two systematic reviews for VTE prophylaxis:
| Personal non-financial specific | Declare and step down as Chair, participation as committee member thereafter |
|
Tenth meeting (09.02.2017) | No change to existing declarations. | N/A | N/A |
|
Eleventh meeting (15.03.2017) |
Paper to be published for protocol relating to research, not any results. Graduated compression stockings as an adjunct to low dose low molecular weight heparin in venous thromboembolism prevention in surgery - a multi-centre randomised controlled trial [ISRCTN13911492] by Mr. Joseph Shalhoub, John Norrie; Christopher Baker; Andrew Bradbury; Karen Dhillon; Tamara Everington; Manj Gohel; Zaed Hamady; Francine Heatley; Jemma Hudson; Beverley J Hunt; Gerard Stansby; Annya Stephens-Boal; David Warwick; Alun H Davies is accepted by the European Journal of Vascular and Endovascular Surgery. | Personal non-financial specific | Declare and participate |
|
Twelfth meeting (19.04.2017) | GAPS protocol (ISRCTN13911492) declared at last committee meeting for which Gerry is one of the authors has now been published. | Personal non-financial specific | Declare and participate |
|
Thirteenth meeting (25.05.2017) | No change to existing declarations | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | No change to existing declarations | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | No change to existing declarations | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | No change to existing declarations | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | No change to existing declarations | No change to existing declarations | No change to existing declarations |
Hazel Trender
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (02.03.2016) | None | N/A | N/A |
|
Second meeting (22.04.2016) | None | N/A | N/A |
|
Third meeting (01.06.2016) | None | N/A | N/A |
|
Fourth meeting (20.07.2016) | Apologies received | N/A | N/A |
|
Fifth meeting (16.09.2016) | None | N/A | N/A |
|
Sixth meeting (19.10.2016) | None | N/A | N/A |
|
Seventh meeting (01.12.2016) | None | N/A | N/A |
|
Eight meeting (05.01.2017) |
Sponsored by MEDI UK to attend the vascular Society annual conference in Manchester in November 2016. This included accommodation and registration. MEDI manufacture compression hosiery amongst other things. | Personal non-financial specific |
Declare and participate (relates to accepted expenses under the DoI policy) |
|
Ninth meeting (08.02.2017) | No change to existing declarations | N/A | N/A |
|
Tenth meeting (09.02.2017) | No change to existing declarations | N/A | N/A |
|
Eleventh meeting (15.03.2017) | No change to existing declarations | N/A | N/A |
|
Twelfth meeting (19.04.2017) | No change to existing declarations | N/A | N/A |
|
Thirteenth meeting (25.05.2017) | No change to existing declarations | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | Apologies received | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | No change to existing declarations | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | No change to existing declarations | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | No change to existing declarations | N/A | N/A |
Jen Watson
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (02.03.2016) | LEO Pharma has sponsored masterclasses at the Marsden hospital; no direct involvement in organizing these. | Non-personal financial specific | Declare and participate |
| Paid for article written in the Nursing Times on VTE and thrombosis. | Personal financial specific |
Declare and participate (Educational article. Nursing Times does not fund or gain from any product relating to VTE) | |
|
Second meeting (22.04.2016) | Approached by Anti-coagulation and Leo Pharma to work alongside them in raising awareness. Discussions are preliminary but may use the Leo Pharma Patient Education film as part of our patient and staff education amongst patients and staff. | Non-personal non-financial specific | Declare and participate |
|
Third meeting (01.06.2016) | No change to existing declarations | N/A | N/A |
|
Fourth meeting (20.07.2016) | No change to existing declarations | N/A | N/A |
|
Fifth meeting (16.09.2016) | No change to existing declarations | N/A | N/A |
|
Sixth meeting (19.10.2016) | Attended the All-party parliamentary thrombosis group (APPTG) round table | Personal non-financial specific | Declare and participate |
|
Seventh meeting (01.12.2016) | No change to existing declarations | N/A | N/A |
|
Eight meeting (05.01.2017) | No change to existing declarations | N/A | N/A |
|
Ninth meeting (08.02.2017) | No change to existing declarations | N/A | N/A |
|
Tenth meeting (09.02.2017) | No change to existing declarations | N/A | N/A |
|
Eleventh meeting (15.03.2017) | No change to existing declarations | N/A | N/A |
|
Twelfth meeting (19.04.2017) | Apologies received | N/A | N/A |
|
Thirteenth meeting (25.05.2017) | No change to existing declarations | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | Apologies received | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | Apologies received | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | No change to existing declarations | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | Apologies received | N/A | N/A |
Martin Yates
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (02.03.2016) | None | N/A | N/A |
|
Second meeting (22.04.2016) | Guest Speaker – VTE Patient Experience – Thrombosis UK. Travel expenses only. | Personal non-financial specific | Declare and participate |
| VTE Patient Experience Story – Hayward Medical Communications | Personal non-financial specific | ||
| Volunteer - Patient Experience Panel – Papworth Hospital | Personal non-financial specific | ||
|
Third meeting (01.06.2016) | Apologies received | N/A | N/A |
|
Fourth meeting (20.07.2016) | No change to existing declarations | N/A | N/A |
|
Fifth meeting (16.09.2016) | No change to existing declarations | N/A | N/A |
|
Sixth meeting (19.10.2016) | No change to existing declarations | N/A | N/A |
|
Seventh meeting (01.12.2016) | No change to existing declarations | N/A | N/A |
|
Eight meeting (05.01.2017) | No change to existing declarations | N/A | N/A |
|
Ninth meeting (08.02.2017) | No change to existing declarations | N/A | N/A |
|
Tenth meeting (09.02.2017) | No change to existing declarations | N/A | N/A |
|
Eleventh meeting (15.03.2017) | No change to existing declarations | N/A | N/A |
|
Twelfth meeting (19.04.2017) | No change to existing declarations | N/A | N/A |
|
Thirteenth meeting (25.05.2017) |
I have been invited to review a research funding application for the National Institute for Health Research Central Commissioning Facility:-The Research for Patient Benefit (RfPB) Programme Research Title: Advanced Resuscitation Room Monitoring Study (ARMS): Randomised controlled trial to test the feasibility of comparing combined advanced minimally-invasive patient monitoring in the emergency department versus standard care. The RfPB programme offers reimbursement for the time and effort involved in commenting on funding applications in accordance with the Guide for CCF public contributors about the payment of fees and expenses. | Personal financial non-specific | Declare and participate |
|
Fourteenth meeting (26.05.2017) | No changes to existing declarations | N/A | N/A |
|
Fifteenth meeting (22.06.2017) |
I have been invited to review a research funding application for the National Institute for Health Research Central Commissioning Facility:-The Research for Patient Benefit (RfPB) Programme Research Title: Advanced Resuscitation Room Monitoring Study (ARMS): Randomised controlled trial to test the feasibility of comparing combined advanced minimally-invasive patient monitoring in the emergency department versus standard care. The RfPB programme offers reimbursement for the time and effort involved in commenting on funding applications in accordance with the Guide for CCF public contributors about the payment of fees and expenses. | Personal financial non-specific | Declare and participate |
|
Sixteenth meeting (28.07.2017) | No change to existing declarations | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | No changes to existing declarations | N/A | N/A |
NGC team
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
First meeting (02.03.2016) | In receipt of NICE commissions | N/A | N/A |
|
Second meeting (22.04.2016) | No change to existing declarations | N/A | N/A |
|
Third meeting (01.06.2016) | No change to existing declarations | N/A | N/A |
|
Fourth meeting (20.07.2016) | No change to existing declarations | N/A | N/A |
|
Fifth meeting (16.09.2016) | No change to existing declarations | N/A | N/A |
|
Sixth meeting (19.10.2016) | No change to existing declarations | N/A | N/A |
|
Seventh meeting (01.12.2016) | No change to existing declarations | N/A | N/A |
|
Eight meeting (05.01.2017) | No change to existing declarations | N/A | N/A |
|
Ninth meeting (08.02.2017) | No change to existing declarations | N/A | N/A |
|
Tenth meeting (09.02.2017) | No change to existing declarations | N/A | N/A |
|
Eleventh meeting (15.03.2017) | No change to existing declarations | N/A | N/A |
|
Twelfth meeting (19.04.2017) | No change to existing declarations | N/A | N/A |
|
Thirteenth meeting (25.05.2017) | No change to existing declarations | N/A | N/A |
|
Fourteenth meeting (26.05.2017) | No change to existing declarations | N/A | N/A |
|
Fifteenth meeting (22.06.2017) | No change to existing declarations | N/A | N/A |
|
Sixteenth meeting (28.07.2017) | No change to existing declarations | N/A | N/A |
|
Seventeenth meeting (07.12.2017) | No change to existing declarations | N/A | N/A |
NIHR team
| Committee meeting | Declaration of interest | Classification | Action taken |
|---|---|---|---|
|
Nicholas Hicks (10.07.2017) | None | N/A | N/A |
- Declarations of interest - Venous thromboembolism in over 16sDeclarations of interest - Venous thromboembolism in over 16s
Your browsing activity is empty.
Activity recording is turned off.
See more...